Patent · US Active

Treatment of acute myeloid leukemia and myelodysplastic syndromes

US9873918B2 · kind B2 · utility

2Cited by

4References

10Claims

0Family size

Assignee

Albert Einstein College of Medicine · US

Inventors

Ulrich Steidl · New Rochelle, US
Laura Barreyro De Pujato · The Bronx, US
Britta Will · The Bronx, US
Amit Verma · Schweinhub, DE

Key dates

Filing date	Aug 9, 2012
Grant date	Jan 23, 2018
Priority date	—
Expiry date	Jan 9, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods are disclosed for diagnosis, prognosis and therapy of acute myeloid leukemia and myelodysplastic syndromes using interleukin 1 receptor accessory protein and other targets.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.